Synergy!
Two new studies by the University of Kansas, supported by The Beljanski Foundation and CIRIS using products provided by Natural Source International, Inc., have been accepted for publication and are in press.
The two studies “Inhibition of pancreatic cancer and potentiation of effects by gemcitabine by an extract of Pao Pereira” and “The plant extract of Pao Pereira potentiates carboplatin effects against ovarian cancer” are important because they confirm the ability of the molecules discovered by Mirko Beljanski to work in synergy with chemotherapy. These results also point out the lack of efficacy of chemotherapy alone. Indeed, the contribution of chemotherapy to 5-year survival is estimated to be 2.3% in Australia and 2.1% in the United States according to an article published in “Clinical Oncology.” This article raises questions considering the cost of hospital treatment, human suffering and the longevity they provide.
It is important to remember that a synergy of action had already been shown by Mirko Beljanski, who, instead of diverting patients away from traditional treatments, emphasized the importance of the simultaneous use of both approaches and made a point in his publications and many interviews.
An English Version of the French DVD “Politiquement Incorrecte, mais Scientifiquement Exacte, L’Histoire Beljanski: des Molecules et des Hommes” (Politically Incorrect, but Scientifically accurate, the Beljanski Story: Molecules and human beings) is in the works.
This pioneering scientist is vindicated yet again, in America, not his home land. (John 4:44 – For Jesus himself testified, that a prophet hath no honor in his own country.